Peroxitech Therapeutics operates as a biopharmaceutical company.
Peroxitech Therapeutics has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in December 2022.
Peroxitech Therapeutics's investors include Xontogeny.
Peroxitech Therapeutics is headquartered in Philadelphia, United States.
Peroxitech Therapeutics operates as a biopharmaceutical company.
Peroxitech Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Peroxitech Therapeutics — Funding & Investors." VCBacked, December 13, 2022, https://www.vcbacked.co/company/peroxitech-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). Peroxitech Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/peroxitech-therapeutics
{{cite web |title=Peroxitech Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/peroxitech-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated